Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 15 Mar 2023
Since the development of functional magnetic resonance imaging in the 1990s, expectations for neuroimaging have skyrocketed as researchers analyze fMRI data of the resting brain and the body of the brain unique to it.
Read Full NewsExtended-release buprenorphine injections increase the number of opioid-free days primarily via direct pathways and by suppressing need-related craving, a causal mediation analysis shows.
Moderate-to-severe fatty pancreas is independently linked to a higher risk for incident type 2 diabetes and chronic kidney disease.
1.
A smartphone app enhances the tracking of recovery following breast and gynecologic oncology surgery, according to JAMA.
2.
Lower screening age calls for more tailored bowel cancer surveillance
3.
Radiation therapy for patients with breast cancer
4.
First-Line HCC Trial's Lenvatinib-Pembrolizumab Combo Misses Target.
5.
Measurable Residual Disease Predicts Real-World AML Relapse
1.
Interpreting Iron Studies: What Your Blood Results Really Mean
2.
Unlocking the Unknown: A Comprehensive Guide to Stage 4 Vulvar Cancer
3.
Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?
4.
Liquid Biopsy in Cancer Screening: An Evidence-Based Review for Clinicians
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
2.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
4.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge